EU ‘negotiating with Valneva’ over COVID-19 vaccine contractThe European Commission is reportedly in advanced discussions with French biotech Valneva about picking up the contract to Share XEU ‘negotiating with Valneva’ over COVID-19 vaccine contracthttps://pharmaphorum.com/news/eu-negotiating-with-valneva-over-covid-19-vaccine-contract/
UK poised to announce booster COVID jabs for over-50sThe UK government is due to announce a large-scale booster vaccine campaign against COVID-19 for all adults aged Share XUK poised to announce booster COVID jabs for over-50shttps://pharmaphorum.com/news/uk-poised-to-announce-booster-covid-jabs-for-over-50s/
Valneva slumps as UK dumps €1.4bn order for COVID-19 jabThe UK has terminated its order for up to 190 million doses of a COVID-19 vaccine developed by Share XValneva slumps as UK dumps €1.4bn order for COVID-19 jabhttps://pharmaphorum.com/news/valneva-slumps-as-uk-dumps-e1-4bn-order-for-covid-19-jab/
UK pledges £5.4bn to NHS to ease COVID-19 treatment backlogNHS England will get an extra £5.4 billion ($7.5 billion) in funding over the next six months to Share XUK pledges £5.4bn to NHS to ease COVID-19 treatment backloghttps://pharmaphorum.com/news/uk-pledges-5-4bn-to-nhs-to-ease-covid-19-treatment-backlog/
UK real-world study finds COVID-19 jab protection wanesA study has found evidence that protection from the AstraZeneca and Pfizer/BioNTech COVID-19 vaccines starts fall off after Share XUK real-world study finds COVID-19 jab protection waneshttps://pharmaphorum.com/news/uk-real-world-study-finds-covid-19-jab-protection-wanes/
MHRA clears Moderna COVID vaccine for 12 to 17 year oldsThe Moderna COVID-19 vaccine has become the second jab to be authorised for use in England, Scotland and Share XMHRA clears Moderna COVID vaccine for 12 to 17 year oldshttps://pharmaphorum.com/news/mhra-clears-moderna-covid-vaccine-for-12-to-17-year-olds/
UK adults asked to record coughs to improve COVID detectionResearchers in the UK are asking adults who have taken a COVID-19 test in the last 72 hours Share XUK adults asked to record coughs to improve COVID detectionhttps://pharmaphorum.com/news/uk-adults-asked-to-record-coughs-to-improve-covid-detection/
UK cues up more Pfizer/BioNTech vaccines as price row loomsThe UK government has started ordering COVID-19 vaccines for a 2022 booster campaign, including a 32 million-dose order Share XUK cues up more Pfizer/BioNTech vaccines as price row loomshttps://pharmaphorum.com/news/uk-cues-up-more-pfizer-biontech-vaccines-as-price-row-looms/
AZ gets European approvals for Forxiga in chronic kidney diseaseAstraZeneca’s Forxiga has become the first SGLT2 inhibitor to be approved in Europe for use in people with Share XAZ gets European approvals for Forxiga in chronic kidney diseasehttps://pharmaphorum.com/news/az-gets-european-approvals-for-forxiga-in-chronic-kidney-disease/
